Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening

Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening

Abstract Background In 2016, it is estimated that there will be 62,700 new cases of kidney cancer in the United States, and 14,240 patients will die from the disease. Because the incidence of kidney renal clear cell carcinoma (KIRC), the most common type of kidney cancer, is expected to continue to...

Full description

Bibliographic Details
Main Authors: Guangchun Han, Wei Zhao, Xiaofeng Song, Patrick Kwok-Shing Ng, Jose A. Karam, Eric Jonasch, Gordon B. Mills, Zhongming Zhao, Zhiyong Ding, Peilin Jia
Format: Article
Language:English
Published: BMC 2017-10-01
Series:BMC Genomics
Subjects:
Pan-cancer screening
Kidney renal clear cell carcinoma (KIRC)
Reverse phase protein Array (RPPA)
Protein expression
Prognostic biomarker
Online Access:http://link.springer.com/article/10.1186/s12864-017-4026-6

Internet

http://link.springer.com/article/10.1186/s12864-017-4026-6

Similar Items